Active surveillance in favorable-risk prostate cancer associated with low long-term mortality
1. In a large prospective cohort study of approximately 1300 men with favorable-risk prostate cancer that underwent active surveillance, there...
Monica graduated from University of California, Berkeley in 2012 with a degree in Integrative Biology. She is currently in her 4th year of medical school at the University of California, San Francisco School of Medicine. She is interested in medical education, curriculum development, and health advocacy for underserved populations. Next year, she hopes to begin residency, and is considering future training in hematology/oncology or pulmonary and critical care medicine. Disclosures: Member, American Medical Association; Member, American College of Obstetrics & Gynecology
1. In a large prospective cohort study of approximately 1300 men with favorable-risk prostate cancer that underwent active surveillance, there...
1. In a phase II clinical trial of 20 patients with platinum-resistant ovarian cancer, the use of nivolumab, a monoclonal...
1. In a randomized controlled trial of over 600 overweight/obese breast cancer survivors, the use of a group-based, behavioral weight-loss...
1. In a prospective cohort study of over 800 patients with stage III ovarian cancer, less than 50% of all...
1. In a randomized controlled trial of 46 breast-cancer survivors with dyspareunia, use of topical lidocaine in the vulvar vestibule...
1. In a retrospective cohort study of over 20 000 survivors of young adult cancers, rates of subsequent hospitalization after...
1. In a prospective cohort study of 138 patients undergoing the combination of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP)...
1. In a secondary analysis of two large prospective trials of over 63,000 women and 41,000 men, increased consumption of...
1. In a retrospective review of a large cancer database of over 1.8 million patients, HIV infection was associated with...
1. In a cross-sectional analysis of a nationally administered survey in the United States of men undergoing prostate specific antigen...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.